AbbVie Inc.
ABBVNYSEPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 3, 2026Score 10/3094% above fair value
$288.84−6.05 (-2.05%)
Close on Nov 2, 2026Market cap $510.41BP/E 81.6Yield 2.30%
AbbVie Managed Care Rebates — Beginning Balance by Year
Managed Care Rebates — Beginning Balance ($M) ($M)
AbbVie Managed Care Rebates — Beginning Balance: $5,525M in FY2025, down 21.3% from a year earlier.
Latest, FY2025
5,525
Period ended Dec 31, 2025
Change on a year earlier
-21.3%
7,020 in FY2024
History
13 years
Since FY2013
Sources
11
Documents cited below
Where the FY2025 figure comes from
“|| Balance as of December 31, 2024 | 7,407 | 5,525 | 1,157”
Source: Form 10-K (abbv-20251231.htm, filed 2026-02-20) ↗
Reported in Form 10-K Item 7 MD&A Rebates & Chargebacks Rollforward.
Annual history
Hover a value to see the sentence it was read from; calculated values show their formula
Cite this data
StockData. (2026). AbbVie Managed Care Rebates — Beginning Balance ($M), annual FY2013–FY2025 [Data set]. Compiled from AbbVie SEC filings and investor materials. https://stockdatahq.com/stocks/abbv/kpis/gtn-managed-care-beg
See every metric in the AbbVie KPI table. Data updated Oct 26, 2026.